Glenmede Trust’s ZELTIQ Aesthetics, Inc. ZLTQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-95
Closed -$5K 2966
2017
Q2
$5K Hold
95
﹤0.01% 2310
2017
Q1
$5K Sell
95
-6,812
-99% -$342K ﹤0.01% 2310
2016
Q4
$300K Buy
+6,907
New +$278K ﹤0.01% 1094
2016
Q1
Sell
-223
Closed -$6K 2794
2015
Q4
$6K Sell
223
-128
-36% -$4.04K ﹤0.01% 2234
2015
Q3
$11K Hold
351
﹤0.01% 2099
2015
Q2
$10K Sell
351
-34
-9% -$1.03K ﹤0.01% 2115
2015
Q1
$11K Sell
385
-62
-14% -$1.98K ﹤0.01% 2114
2014
Q4
$12K Buy
447
+122
+38% +$3.18K ﹤0.01% 2177
2014
Q3
$7K Sell
325
-19,675
-98% -$390K ﹤0.01% 2193
2014
Q2
$303K Hold
20,000
﹤0.01% 1027
2014
Q1
$392K Hold
20,000
﹤0.01% 938
2013
Q4
$378K Hold
20,000
﹤0.01% 944
2013
Q3
$180K Hold
20,000
﹤0.01% 1167
2013
Q2
$127K Buy
+20,000
New +$95.1K ﹤0.01% 1230

Glenmede Trust's ZLTQ Position: Q3 2017 in Review

Glenmede Trust sold out of ZELTIQ Aesthetics, Inc. (ZLTQ) in Q3 2017, closing a stake of 95 shares — an estimated $5K sold.

Glenmede Trust first reported a position in ZLTQ in Q2 2013 and held it in 14 quarters. The position peaked at $392K in Q1 2014. 1 fund tracked by Wall St. Rank holds ZLTQ as of Q3 2017.

  • Glenmede Trust reported no remaining ZELTIQ Aesthetics, Inc. position as of Q3 2017 after selling out during the quarter.
  • Glenmede Trust sold 95 ZELTIQ Aesthetics, Inc. shares in Q3 2017, an estimated $5K.
  • Glenmede Trust first reported a position in ZELTIQ Aesthetics, Inc. in Q2 2013 and held it in 14 quarters.
  • Glenmede Trust's ZELTIQ Aesthetics, Inc. position peaked at $392K in Q1 2014.
  • 1 fund tracked by Wall St. Rank held ZELTIQ Aesthetics, Inc. as of Q3 2017.

Based on Glenmede Trust's 13F filing for Q3 2017, filed 14 Nov 2017.